INO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Inovio Pharmaceuticals Inc (INO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, options data shows weak sentiment, and there are no significant positive catalysts or recent news to support a strong upward movement. Analysts have also lowered their price target, and there is no recent congress trading data or financial performance data to suggest a compelling reason to invest now.
The MACD histogram is negative (-0.0027) and contracting, RSI is neutral at 42.867, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 1.109 with resistance levels at 1.152 and 1.177, and support levels at 1.067 and 1.042. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news or significant positive developments.
Analyst H.C. Wainwright lowered the price target from $3 to $2.50 due to increasing share counts. Technical indicators are bearish, and the stock has a 70% chance of declining in the short term (-1.68% next day, -1.1% next week).
No financial data available for the latest quarter.
H.C. Wainwright maintains a Neutral rating and has lowered the price target to $2.50 from $3, citing increasing share counts.
